Drug Approval | April 21, 2022
Saraq Hepatitis C kit receives CDSCO nod
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Medical experts point to a growing body of research linking energy drinks to liver injury
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The new assay consolidates screening for four major viral threats into a single workflow
The protections extend through at least 2035, with the potential for further extensions
Huwel’s diagnostic solutions leverage open RT-PCR system
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
Subscribe To Our Newsletter & Stay Updated
